547
Views
24
CrossRef citations to date
0
Altmetric
Review

Risk factors for premenstrual asthma: a systematic review and meta-analysis

, , , , &
Pages 57-72 | Received 27 May 2016, Accepted 07 Dec 2016, Published online: 21 Dec 2016

References

  • Zein JG, Erzurum SC. Asthma is different in women. Curr Allergy Asthma Rep. 2015;15:28. DOI:10.1007/s11882-015-0528-y
  • Frank RT. The hormonal causes of premenstrual tension. Arch Neurol Psychiat. 1931;26:1053.
  • Claude F, Allewany VR. Asthme et menstruation. Presse Med. 1938;38:755..
  • Rees L. An aetiological study of premenstrual asthma. J Psychosom Res. 1963;7:191–197.
  • Eliasson O, Scherzer HH, De Graff AC Jr. Morbidity in asthma in relation to the menstrual cycle. J Allergy Clin Immunol. 1986;77:87–94..
  • Agarwal AK, Shah A. Menstrual-linked asthma. J Asthma. 1997;34:539–545.
  • Chhabra SK. Premenstrual asthma. Indian J Chest Dis Allied Sci. 2005;47:109–116.
  • Van Den Akker O, Steptoe A. The pattern and prevalence of symptoms during the menstrual cycle. Br J Psychiatry. 1985;147:164–169.
  • Brenner BE, Holmes TM, Mazal B, et al. Relation between phase of the menstrual cycle and asthma presentations in the emergency department. Thorax. 2005;60(10):806–809.
  • Wegienka G, Hasiec E, Boushey H, et al. Studying forced expiratory volume at 1 second over menstrual segments in asthmatic and non-asthmatic women: assessing protocol feasibility. BMC Res Notes. 2012;5:261. http://www.biomedcentral.com/1756-0500/5/261
  • Macsali F, Svanes C, Sothern RB, et al. Menstrual cycle and respiratory symptoms in a general Nordic-Baltic population. Am J Respir Crit Care Med. 2013;187:366–373..
  • Ensom MH, Chong E, Carter D. Premenstrual symptoms in womenwith premenstrual asthma. Pharmacotherapy. 1999;19:374–382.
  • Halbreich U, Endicott J. Methodological issues in studies of premenstrual changes. Psychoneuroendocrinology. 1985;10:15–32.
  • Murphy VE, Gibson PG. Premenstrual asthma: prevalence, cycle to-cycle variability and relationship to oral contraceptive use and menstrual symptoms. J Asthma. 2008;45:696–704.
  • Balzano G, Fuschillo S, Melillo G, et al. Asthma and sex hormones. Allergy. 2001;56:13–20.
  • Stanford KI, Mickleborough TD, Ray S, et al. Influence of menstrual cycle phase on pulmonary function in asthmatic athletes. Eur J Appl Physiol. 2006;96:703–710.
  • Oguzulgen IK, Turktas H, Erbas D. Airway Inflammation in premenstrual asthma. J Asthma. 2002;39(6):517–522..
  • Pereira-Vega A, Sánchez Ramos JL, Maldonado Pérez JA, et al. Variability in the prevalence of premenstrual asthma. Eur Respir J. 2010;35:980–986.
  • Gibas CJ, Coutts II, Lock R, et al. Premenstrual exacerbation of asthma. Thorax. 1984;39:833–836.
  • Thornton J, Lewis J, Lebrun CM, et al. Clinical characteristics of women with menstrual-linked asthma. Respir Med. 2012;106:1236–1243.
  • Gibbs CJ, Coutts II, Löck RR, et al. Premenstrual exacerbation of asthma. Thorax. 1984;39:833–836.
  • Cross S. Asthma and the menstrual cycle. Nurs Stand. 1994;8(20):23–28.
  • Haggerty CL, Ness RB, Kelsey S, et al. The impact of oestrogen and progesterone on asthma. Ann Allergy Asthma Immunol. 2003;90:284–291.
  • Karpel JP, Juliette LW. Asthma and women, Part 3: perimenstrual asthma, effects of hormone therapy. J Crit Illnes. 2000;15(5):265–272.
  • Redmond AM, James AW. Nolan SH and self TH. premenstrual asthma: emphasis on drug therapy options. J Asthma. 2004;41(7):681–687.
  • Vrieze A, Postma S, Kerstjens HAM. Perimenstrual asthma: a syndrome without known cause or cure. J Allergy Clin Immunol. 2003;112:271–282.
  • Enright T, Lim DT, Devnani R, et al. Clinical exacerbation of bronchial asthma. Clinical Allergy – Immunology Rounds. 1987;58:405-6 (Part One) and 452-3 (Part Two).
  • Chandler MH, Schuldheisz S, Phillips BA, et al. Premenstrual asthma: the effect of oestrogens on symptoms, pulmonary function, and beta 2-receptors. Pharmacotherapy. 1997;17(2):224–234.
  • Murray RD, New JP, Barber PV, et al. Gonadotrophin-releasing hormone analogues: a novel treatment for premenstrual asthma. Eur Respir J. 1999;14(4):966–967.
  • Wyatt K, Dimmock P, Jones P, et al. Efficacy of progesterone and progestagens in management of premenstrual syndrome; systematic review. Bmj. 2001;323:776.
  • Derimanov GS, Oppenheimer J. Exacerbation of premenstrual asthma caused by an oral contraceptive. Ann Allergy Asthma Immunol. 1998;81(3):243–246.
  • Ensom MH, Chong G, Zhou D, et al. Estradiol in premenstrual asthma: a double-blind, randomized, placebo-controlled, crossover study. Pharmacotherapy. 2003;23(5):561–571..
  • Nakasato H, Ohrui T, Sekizawa K, et al. Prevention of severe premenstrual asthma attacks by leukotriene receptor antagonists. J Allergy Clin Immunol. 1999;104:585–588.
  • Pasaoglu G, Mungan D, Abadoglu O, et al. Leukotriene receptor antagonists: a good choice in the treatment of pre-menstrual asthma?. J Asthma. 2008;45:95–99.
  • Moher D, Liberati A, Tetzlaff J, et al., PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8(5):336–341. Epub 2010 Feb 18. Erratum in: Int J Surg. 2010; 8(8):658. [Medline: 20171303].10.1016/j.ijsu.2010.02.007
  • Urrutia G, Bonfill X. PRISMA declaration: a proposal to improve the publication of systematic reviews and meta-analysis. Med Clin (Barc). 2010;135(11):507–511.
  • Wilczynski NL, McKibbon KA, Haynes RB. Sensitive clinical queries retrieved relevant systematic reviews as well as primary studies: an analytic survey. J Clin Epidemiol. 2011;64(12):1341–1349.
  • Critical Appraisal Skills Programme (CASP) international. Available at:: http://www.caspinternational.org/mod_product/uploads/CASP%20Case%20Control%20Study%20Checklist%2031.05.13.pdf.
  • Berra S, Elorza-Ricart JM, Estrada MD, et al. Instrumento para la lectura crítica y la evaluación de estudios epidemiológicos transversales. Gac Sanit. 2008;22(5):492–497. ISSN 0213-9111.
  • Eliasson O, Longo M, Dore-Duffy P, et al. Serum 13-14-diOH-15-keto-prostaglandin F2 alpha and airway response to meclofenamate and metaproterenol in relation to the menstrual cycle. J Asthma. 1986;23:309–319.
  • Forbes L, Jarvis D, Bumey P. Is pre-menstrual asthma related to use of aspirin or non-steroidal anti-inflammatory drugs?. Respir Med. 2000;94:828–829.
  • Gorovenko N, Ebrahimi M, Podolskaya S. Genetic polymorphism of Glutathione-S- Transferase M1. T1 and susceptibility to premenstrual asthma. in Ukrainian population. Chest. 2005;128(Supp 4):239S–240S.
  • Hanley SP. Asthma variation with menstruation. Br J Dis Chest. 1981;75:306–308.
  • Pereira-Vega A, Sánchez Ramos JL, Maldonado Pérez JA, et al. Premenstrual asthma and atopy markers. Ann Allergy, Asthma Immunol. 2010;105(3):218–222.
  • Pereira Vega A, Sánchez Ramos JL, Gil Muñoz FJ, et al. Premenstrual asthma and symptoms related to premenstrual syndrome. J Asthma. 2010;47:835–840.
  • Pereira-Vega A, Sánchez Ramos JL, Vázquez Oliva R, et al. Premenstrual asthma and female sex hormones. J Investig Allergol Clin Immunol. 2012;22(6):437–439.
  • Pereira-Vega A, Sánchez Ramos JL, Maldonado Pérez JA, et al. Premenstrual asthma and leukotriene variations in the menstrual cycle. Allergologia Et Immunophatology. 2012;40(6):368–373..
  • Rao CK, Moore CG, Bleecker E, et al. Characteristics of perimenstrual asthma and its relation to asthma severity and control. data from the severe asthma research program. Chest. 2013;143(4):984–992.
  • Rubio Ravelo L, Gago Rodríguez B, Almirall Collazo JJ, et al. Comparative study of progesterone, estradiol and cortisol concentrations in asthmatic and non-asthmatic women. Allergol Immunopathol (Madr). 1988;16:263–266.
  • Shames RS, Heilbron DC, Janson SL, et al. Clinical differences among women with and without self-reported perimenstrual asthma. Ann Allergy Asthma Immunol. 1998;81:65–71.
  • Siroux V, Oryszczyn MP, Varraso R, et al. Facteurs environnementaux de l’asthme sévère et de l’allergie: résultats de l’étude EGEA. Rev Mal Resp. 2007;24(5):599–608.
  • Suzuki K, Hasegawa T, Sakagami T, et al., the Niigata Asthma Treatment Study Group. Analysis of perimenstrual asthma based on questionnaire surveys in Japan. Allergol Int. 2007;56:249–255.
  • Dratva J, Schindler C, Curjuric I, et al., on behalf of the SAPALDIA Team. Perimenstrual increase in bronchial hyperreactivity in premenopausal women: results from the population-based SAPALDIA 2 cohort. J Allergy Clin Immunol. 2010;125:823–829.
  • Tan KS, MacFarlane LC, Lipworth BJ. Modulation of airway reactivity and peak flow variability in asthmatics receiving the oral contraceptive pill. Am J Respir Crit Care Med. 1997;155:1273–1277.
  • Mandhane PJ, Hanna SE, Inman MD, et al. Changes in exhaled nitric oxide related to oestrogen and progesterone during the menstrual cycle. Chest. 2009;136:1301–1307.
  • Shibasaki M, Takeda K, Sumazaki R, et al. Premenstrual asthma with seasonal variation. Ann Allergy. 1992;68:315–318.
  • Martínez-Moragón E, Plaza V, Serrano J, et al. Near – fatal asthma related to menstruation. J Allergy Clin Inmunology. 2004;103(2):242–244.
  • Roby RR, Richardson RH, Vojdani A. Hormone allergy. Am J Reprod Immunol. 2006;55(4):307–313.
  • Agarwal SK, Marshall GD Jr. Perimenstrual alterations in type1/type-2 cytokine balance of normal women. Ann Allergy Asthma Immunol. 1999;83:222–228.
  • Mirdal GM, Petersson B, Weeke B, et al. Asthma and menstruation: the relationship between psychological and bronchial hyperreactivity. Br J Med Psychol. 1998;71(Pt 1):47–55.
  • Skobellof EM, Spivey WH, Silverman R, et al. The effect of the menstrual cycle on asthma presentations in the emergency department. Arch Intern. 1996;156:1837–1840.
  • Zimmerman JL, Woodruff PG, Clark S, et al., on behalf of the MARC. Investigators. relation between phase of menstrual cycle and emergency department visits for acute asthma. Am J Respir Crit Care Med. 2000;162:512–515.
  • Ediger D, Bahcetepe D. The prevalence and evaluation of premenstrual asthma, comparing premenstrual symptoms with asthmatic and healthy women. Eur Respir J. 2015;46(suppl 59) PA4015. DOI: 10.1183/13993003.congress-2015.PA4015 .
  • Becklake MR, Kauffmann F. Gender differences in airway behaviour over the human lifespan. Thorax. 1999;54(12):1119–1138.
  • Al-Sahab B, Hamadeh MJ, Ardern CI, et al. Early menarche predicts incidence of asthma in early adulthood. Am J Epidemiol. 2011;1(1):64–70.
  • Macsali F, Real FG, Plana E, et al. Early age at menarche, lung function, and adult asthma. Am J Respir Crit Care Med. 2011;1(1):8–14.
  • Sunyer J, Antó JM, Kogevinas M, et al. Risk factor for asthma in young adults. Spanish group of the European community. Respiratory health survey. Eur Respir J. 1997;10(11):2490–2494.
  • Schatz M, Dombrowski MP, Wise R, et al. Asthma morbidity during pregnancy can be predicted by severity classification. J Allergy Clin Immunol. 2003;112:283–288.
  • Real FG, Svanes C, Omenaas ER, et al. Lung function, respiratory symptoms, and the menopausal transition. J Allergy Clin Immunol. 2008;121:72–80.
  • Ulrik CS, Backer V, Dirksen A. Mortality and decline in lung function in 213 adults with bronchial asthma: a ten-year follow up. J Asthma. 1992;29:29–38.
  • Terral P, Godard F, Michel B, et al. Influence des estrogènes sur l’histamino-libération du sang total induite par des allergènes in vitro. C.R.Soc.Biol. 1981;175:247-252
  • Vliagoftis H, Dimitriadou V, Boucher W, et al. Estradiol augments while tamoxifen inhibits rat mast cell secretion. Int Arch Allergy Immunol. 1992;98:398–409.
  • Hamano N, Terada N, Maesako K, et al. Effect of sex hormones on eosinophilic inflammation in nasal mucosa. Allergy Asthma Proc. 1998;19:263–269.
  • Jamieson PM, Nyirenda MJ, Walker BR, et al. Interactions between estradiol and glucocorticoid regulatory effects on liver-specific glucocorticoid-inducible genes: possible evidence for a role of hepatic 11beta-hydroxysteroid dehydrogenase type. J Endocrinol. 1999;160:103–109.
  • Tai P, Wang J, Jin H, et al. Induction of regulatory T cells by physiological level oestrogen. J Cell Physiol. 2008;214:456–464.
  • Mitchell VL, Gershwin LJ. Progesterone and environmental tobacco smoke act synergistically to exacerbate the development of allergic asthma in a mouse model. Clin Exp Allergy. 2007;37:276–286.
  • Hackney JF, Holbrook NJ, Grasso RJ. Progesterone as a partial glucocorticoid agonist in L929 fibroblasts: effect on cell growth, glutamine synthetase induction and glucocorticoid receptors. J Steroid Biochem. 1981;14:971–977.
  • Townsend EA, Thompson MA, Pabelick CM, et al. Rapid effects of oestrogen on intracellular Ca2 regulation in human airway smooth muscle. Am J Physiol Lung Cell Mol Physiol. 2010;298:L521–L530.
  • Keselman A, Heller N. Estrogen signaling modulates allergic inflammation and contributes to sexual differences in asthma. Front Immunol. 2015;6:1–14. DOI:10.3389/fimmu.2015.00568
  • Kaur S, Behera D. Pre and post menstrual peak flow rates and symptoms amongst patients with bronchial asthma. J Assoc Physicians India. 2010;58:331.
  • Ackerman LS. Sex hormones and the genesis of autoimmunity. Arch Dermatol. 2006;142(3):371–376. DOI:10.1001/archderm.142.3.371
  • D’Agostino B, Stanziola A, Polverino M, et al. Bronchial reactivity and phases of menstrual cycle in asthmatic women. Allergy. 2009;64(Suppl. 90):561–562
  • Matteis M, Polverino F, Spaziano G, et al. Effects of sex hormones on bronchial reactivity during the menstrual cycle. BMC Pulm Med. 2014;14:108.
  • Tan KS, McFarlane LC, Lipworth B. Paradoxical down-regulation and desensitization of p2-adrenoceptors by exogenous progesterone in female asthmatics. Chest. 1997;111:847–851.
  • Tan KS, McFarlane LC, Lipworth BJ. β2-Adrenoceptor regulation and function in female ashtmatics patients receiving the oral combined contraceptive pill. Chest. 1998;113:2079–2086.
  • Tan KS. Premenstrual asthma: epidemiology, pathogenesis and treatment. Drugs. 2001;61(14):2079–2086.
  • Alberts WM. ‘Circa menstrual’ rhythmicity and asthma. Chest. 1997;111(4):840–842.
  • Black PN. Changes in airway beta-adrenergic responses during the menstrual cycle in women with premenstrual asthma. Thorax. 1987;42(3):232.
  • Jeziorska M, Salamonsen LA, Woolley DE. Mast cell and eosinophil distribution and activation in human endometrium throughout the menstrual cycle. Biol Reprod. 1995;53:312–320.
  • Matai R, Barker MD. Cyclical variation of serum neutral endopeptidase lost in asthmatics: a pilot study. Pathophysiology. 2007;14:29–33.
  • Skoczynski S, Semik-Orzech A, Sozanska E, et al. Bronchial hyperactivity in perimenstrual asthma is higher than in non-PMA asthmatics and correlates with sputum levels of eotaxin and IL-4. Erj. 2014;44(Suppl 58):P1031.
  • Dean N, Sadat A, Nunnery S, et al. Montelukast provides superior efficacy for perimenstrual asthma exacerbations not controlled by inhaled steroids [abstract]. Chest. 2001;120:208S.
  • Dean NL. Perimenstrual asthma exacerbations and positioning of leukotriene-modifying agents in asthma. management guidelines. Chest. 2001;120(6):2116–2117.
  • Hernández-Colin A, Zarate Treviño A, Martínez-Cairo Cueto S. Asma premenstrual: relación con hormonas. Revista Alergia México. 1997;44(2):35–38.
  • Lemanske RF, Busse WW. Asthma: clinical expression and molecular mechanisms. J Allergy Clin Immunol. 2010;125:S95–102.
  • Broide DH, Finkelman F, Bochner BS, et al. Advances in mechanisms of asthma, alergy and immunology in 2010. J Allergy Clin Immunol. 2011;127:689–695.
  • Corren J. Cytokine inhibition in severe asthma: current knowledge and future directions.. Curr Opin Pulm Med. 2011;17:29–33.
  • Desay D, Brightling C. Cytokines and cytokines-specific therapy in asthma.Adv. Clin Chem. 2012;57:57–97.
  • Whitcomb BW, Mumford SL, Perkins NJ, et al. Urinary cytokine and chemokine profiles across the menstrual cycle in healthy reproductive-aged women. Fertil Steril. 2014;101(5):1383–1391.
  • Bertone-Johnson ER, Ronnenberg AG, Houghton SC, et al. Association of inflammation markers with menstrual symptom severity and premenstrual syndrome in young women. Hum Reprod. 2014;29(9):1987–1994.
  • Skoczynsky S, Semik-Orzech A, Szanecki W, et al. Perimenstrual Asthma as a Gynecological and Pulmonological Clinical Problem. Adv Clin Exp Med. 2014;23(4):665–668.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.